OESTROGENERATION CIC

Company limited by guarantee

Company Registration Number:
14025042 (England and Wales)

Unaudited statutory accounts for the year ended 30 April 2026

Period of accounts

Start date: 1 May 2025

End date: 30 April 2026

OESTROGENERATION CIC

Contents of the Financial Statements

for the Period Ended 30 April 2026

Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

OESTROGENERATION CIC

Profit And Loss Account

for the Period Ended 30 April 2026

2026 2025


£

£
Turnover: 21,192 32,380
Cost of sales: ( 9,200 ) ( 13,515 )
Gross profit(or loss): 11,992 18,865
Administrative expenses: ( 17,117 ) ( 20,371 )
Operating profit(or loss): (5,125) (1,506)
Profit(or loss) before tax: (5,125) (1,506)
Profit(or loss) for the financial year: (5,125) (1,506)

OESTROGENERATION CIC

Balance sheet

As at 30 April 2026

Notes 2026 2025


£

£
Current assets
Cash at bank and in hand: 1,277 6,403
Total current assets: 1,277 6,403
Creditors: amounts falling due within one year: 3 ( 600 ) ( 600 )
Net current assets (liabilities): 677 5,803
Total assets less current liabilities: 677 5,803
Total net assets (liabilities): 677 5,803
Members' funds
Profit and loss account: 677 5,803
Total members' funds: 677 5,803

The notes form part of these financial statements

OESTROGENERATION CIC

Balance sheet statements

For the year ending 30 April 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 29 June 2026
and signed on behalf of the board by:

Name: Harry Lindsey
Status: Director

The notes form part of these financial statements

OESTROGENERATION CIC

Notes to the Financial Statements

for the Period Ended 30 April 2026

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

OESTROGENERATION CIC

Notes to the Financial Statements

for the Period Ended 30 April 2026

  • 2. Employees

    2026 2025
    Average number of employees during the period 2 2

OESTROGENERATION CIC

Notes to the Financial Statements

for the Period Ended 30 April 2026

3. Creditors: amounts falling due within one year note

2026 2025
£ £
Accruals and deferred income 600 600
Total 600 600

COMMUNITY INTEREST ANNUAL REPORT

OESTROGENERATION CIC

Company Number: 14025042 (England and Wales)

Year Ending: 30 April 2026

Company activities and impact

In the space provided below, please insert a general account of the company’s activities in the financial year to which the report relates, including a description of how they have benefited the community. Oestrogeneration is an online magazine & events company for and by trans women. During this financial year, Oestrogeneration has a been able to serve the community by hosting weekly fundraisers from November 2023 that have given directly to community members in need of life-saving healthcare. We released the first print issue of our magazine that hired a team of trans women to write & design the magazine, creating work that disrupts the transphobic media landscape in the UK. We have hosted numerous events for our community from night club events to cinema screenings, creating a safe space to cultivate connection & support amongst trans women and our allies. We have hosted weekly fundraisers that give opportunities for members of the trans community to perform weekly. All money raised through these events is given back to individuals in our community who are raising money for their gender affirming care. We have been able to donate to over 100 fundraisers through this work & it has been the primary focus for our organisation during this financial year.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

The total amount paid or receivable by directors in respect of qualifying services was £3,712. There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.

Transfer of assets

Transfers of assets during this time include donations from weekly fundraiser events for members of the trans community, donated via Gofundme. These donations (BODY SWAP DONATION) are remitted to the beneficiaries during the period.

This report was approved by the board of directors on
29 June 2026

And signed on behalf of the board by:
Name: Harry Lindsey
Status: Director